Cardiovascular and Neurohumoral Responses Following Burn Injury

Archives of Surgery

Volumn 125, Issue 8, 1990, Pages 1065-1069

  Crum, Ralph L ^a   Dominic, William ^a   Hansbrough, John F ^a   Shackford, Steven R ^a   Brown, Marvin R ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; VASOPRESSIN;

ADULT; AGED; ARTICLE; BURN; CLINICAL ARTICLE; FEMALE; HEMODYNAMIC MONITORING; HORMONE RELEASE; HUMAN; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; BURNS; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGE; NEUROTRANSMITTERS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0025090532     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1990.01410200129021     Document Type: Article

References (57)

1. Demling RH, Kramer GC, Gunther R, Nerlich M. Effect of nonprotein colloid on postburn edema formation in soft tissues and lung. Surgery. 1984;95:595-601.
2. Demling RH, Kramer G, Harms B. Role of thermal injury-induced hypoproteinemia on fluid flux and protein permeability in burned and nonburned tissue. Surgery. 1984;95:136-143.
3. Demling RH. Fluid resuscitation after major burns. JAMA. 1983; 250:1438-1440.
4. Aulick LH, Wilmore DW, Mason AD Jr, Pruitt BA Jr. Influence of the burn wound on peripheral circulation in thermally injured patients. Am J Physiol. 1977;233:H520-H526.
5. Wilmore DW, Aulick LH, Mason AD Jr, Pruitt BA Jr. Influence of the burn wound on local and systemic responses to injury. Ann Surg. 1977;186:444-458.
6. Demling RH. Fluid replacement in burned patients. Surg Clin North Am. 1987;67:15-30.
7. Baxter CR. Guidelines for fluid resuscitation. J Trauma. 1981;21:687-689.
8. Tranbaugh RF, Lewis FR, Christensen JM, Elings VB. Lung water changes after thermal injury. Ann Surg. 1980;192:479-490.
9. Brizio-Molteni L, Molteni A, Cloutier LC, Rainey S. Incidence of post burn hypertensive crisis in patients admitted to two burn centers and a community hospital in the United States. Scand J Plast Reconstr Surg. 1979;13:21-28.
10. Pruitt BA Jr, Mason AD Jr, Moncrief JA. Hemodynamic changes in the early postburn patient: the influence of fluid administration and of a vasodilator (hydralazine). J Trauma. 1971;11:36-46.
11. Hilton JG, McPherson MB, Marullo DS. The relationship between postburn increases in peripheral resistance and vasopressin. Burns. 1986;12:410-414.
12. Raffa J, Trunkey D. Myocardial depression in acute thermal injury. J Trauma. 1978;18:90-93.
13. Davies DM, Pusey CD, Rainford DJ, Brown JM, Bennett JP. Acute renal failure in burns. Scand J Plast Reconstr Surg. 1979;13:189-192.
14. Pruitt BA Jr. Fluid resuscitation for extensively burned patients. J Trauma. 1981;21:690-692.
15. Bowser-Wallace BH, Cone JB, Caldwell FT Jr. Hypertonic lactated saline resuscitation of severely burned patients over 60 years of age. J Trauma. 1985;25:22-26.
16. Davies JWL. The endocrine response. In: Physiological Responses to Burning Injury. Orlando, Fla: Academic Press Inc; 1982:530-567.
17. Dolecek R, Adamkova M, Sotornikova T, Zavada M, Kracmar P. Endocrine response after burn. Scand J Plast Reconstr Surg. 1979;13:9-16.
18. Becker RA, Vaughan GM, Goodwin CW Jr, et al. Plasma norepinephrine, epinephrine, and thyroid hormone interactions in severely burned patients. Arch Surg. 1980;115:439-443.
19. Crum R, Bobrow B, Shackford S, Hansbrough J, Brown MR. The neurohumoral response to burn injury in patients resuscitated with hypertonic saline. J Trauma. 1988;28:1181-1187.
20. Vernersson E, Ahlgren I, Aronsen KF, Koopmann H. The effects of lysine-vasopressin on hemodynamics during early post burn period in pigs. Acta Chir Scand. 1982;148:491-497.
21. Liard JF. Cardiovascular effects of vasopressin: some recent aspects. J Cardiovasc Pharm. 1986;8:S61-S65.
22. Lund CC, Browder NC. The estimation of areas of burn. Surg Gynecol Obstet. 1944;79:325-358.
23. Crum R, Bobrow B, Hansbrough J, Brown M, Norton C. Neurohumoral regulators in burn injury. In: Abstracts of the Geneva International Congress on Burn Injuries; 1987; Geneva, Switzerland. Abstract 12B02.
24. Merkelbuch U, Czernichow P, Gaillard RC, Vallotton MB. Radioimmunoassay of [8-arginine]-vasopressin. Acta Endocrinol. 1975;80:453-464.
25. Brown MR, Allen R, Fisher LA. Assessment of peptide regulation of the autonomic nervous system. In: Conn PM, ed. Methods in Enzymology: Neuroendocrine Peptides. Orlando, Fla: Academic Press Inc; 1989:431-443.
26. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977;21:625-636.
27. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA. 1982;79:5485-5489.
28. Lundberg JM, Pernow J, Lacroix JS. Neuropeptide Y: sympathetic cotransmitter and modulator? News Physiol Sci. 1989;4:13-17.
29. Hilton JG, Marullo DS. Trauma induced increases in plasma vasopressin and angiotensin II. Life Sci. 1987;41:2195-2200.
30. Reid IA. Inhibition of renin secretion by vasopressin: mechanisms and physiological role. In: Schrier RW, ed. Vasopressin. New York, NY: Raven Press; 1985:21-28.
31. Tipayamontri U, Young DB, Nuwayhid S, Scott RE. Analysis of the cardiovascular effects of arginine vasopressin on conscious dogs. Hypertension. 1987;9:371-378.
32. Suzuki K, Odagiri T, Takasu N, et al. Changes in left ventricular preload and contractility following severe burns in the dog. Heart Vessels. 1986;2:147-153.
33. Liard JF. Atropine potentiates the pressor effect of arginine-vasopressin in conscious dogs. J Cardiovasc Pharmacol. 1984;6:867-871.
34. Schwartz J, Liard JF, Ott C, Cowley AW Jr. Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs. Am J Physiol. 1985;249:H1001-H1008.
35. Burnett JC Jr, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol. 1984;247:F863-F866.
36. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology. 1985;40:277-279.
37. Schwartz J, Ott C, Morales O, Reid IA. Role of antidiuretic activity in the inhibition of renin secretion by vasopressin in anesthetized dogs. Peptides. 1986;7:91-96.
38. Meyer-Lehnert H, Tsai P, Schrier RW. Atrial natriuretic factor (ANF) inhibits arginine vasopressin-stimulated Ca 2+ fluxes and cell contraction in vascular smooth muscle cells. Klin Wochenschr. 1987;65(suppl 8):115-121.
39. Obana K, Naruse M, Inagami T, et al. Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary. Biochem Biophys Res Commun. 1985;132:1088-1094.
40. Kleinert HD, Maack T, Atlas SA, Januszewicz A, Sealey JE, Laragh JH. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. Hypertension. 1984;6(suppl I):I143-I147.
41. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985;313:1330-1340.
42. Atarashi K, Mulrow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Clin Invest. 1985;76:1807-1811.
43. Liard JF. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Circ Res. 1986;58:631-640.
44. Boyle WA III, Segel LD. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. Am J Physiol. 1986;251:H734-H741.
45. Laird JF. Effects of arginine vasopressin on regional circulations. In: Schrier RW, ed. Vasopressin. New York, NY: Raven Press; 1985:59-68.
46. Wilson MF, Brackett DJ, Archer LT, Hinshaw LB. Mechanisms of impaired cardiac function by vasopressin. Ann Surg. 1980;191:494-500.
47. Blei AT, Groszmann RJ, Gusberg R, Conn HO. Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs. Dig Dis Sci. 1980;25:688-694.
48. Liard JF, Deriaz O, Schelling P, Thibonnier M. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs. Am J Physiol. 1982;243:H663-H669.
49. Montani JP, Liard JF, Schoun J, Mohring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res. 1980;47:346-355.
50. Liard JF. Effects of intra-arterial arginine-vasopressin infusions on peripheral blood flows in conscious dogs. Clin Sci. 1986;71:713-721.
51. Wiles PG, Grant PJ, Davies JA. The differential effect of arginine vasopressin on skin blood flow in man. Clin Sci. 1986;71:633-638.
52. Liard JF. Vasopressin in cardiovascular control: role of circulating vasopressin. Clin Sci. 1984;67:473-481.
53. Khayyal MA, Eng C, Franzen D, Breall JA, Kirk ES. Effects of vasopressin on the coronary circulation: reserve and regulation during ischemia. Am J Physiol. 1985;248:H516-H522.
54. Schmid PG, Sharabi FM, Guo GB, Abboud FM, Thames MD. Vasopressin and oxytocin in the neural control of the circulation. Fed Proc. 1984;43:97-102.
55. Ebert TJ, Cowley AW Jr, Skelton M. Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man. J Clin Invest 1986;77:1136-1142.
56. Courtice GP, Kwong TE, Lumbers ER, Potter EK. Excitation of the cardiac vagus by vasopressin in mammals. J Physiol. 1984;354:547-556.
57. Brooks DP, Share L, Crofton JT. Vasopressin: the control of its release and cardiovascular actions. In: Schrier RW, ed. Vasopressin. New York, NY: Raven Press; 1985:69-78.